The Use of Antipsychotic and Anticholinergic Antiparkinson Drugs in Norway After the Withdrawal of Orphenadrine

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.2009.03446.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Orphenadrine--Presence in Patients Not Using Antipsychotic Drugs

British Journal of Psychiatry
MedicinePsychiatryMental Health
1999English

Levodopa in Parkinsonism: The Effects of Withdrawal of Anticholinergic Drugs

BMJ
1971English

The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2019English

Modern View on the Use of Antipsychotic Drugs in the Practice of a Hospital Doctor

Effective Pharmacotherapy
2020English

Anticholinesterases and Anticholinergic Drugs

Continuing Education in Anaesthesia Critical Care & Pain
2004English

6-Hydroxydopamine and Anticholinergic Drugs

Science
MultidisciplinaryPhilosophy of ScienceHistory
1978English

Withdrawal Versus Continuation of Chronic Antipsychotic Drugs for Behavioural and Psychological Symptoms in Older People With Dementia

Cochrane Database of Systematic Reviews
2013English

Audit of Antipsychotic and Anticholinergic Prescribing: Leeds CMHT 2000–1

Psychiatric Bulletin
2003English

Concomitant Use of Two or More Antipsychotic Drugs Is Common in Sweden

Therapeutic Advances in Psychopharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy